Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
University of Groningen · UNSW Sydney · +13 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
212
total citations
- FWCI
- 37.20
- Percentile
- 100%
- References
- 30
Citations per year
Authors
731- HJHiddo J.L. HeerspinkCorresponding
University of Groningen, UNSW Sydney, The George Institute for Global Health
- JRJai Radhakrishnan
Columbia University
- CECharles E. Alpers
University of Washington
- JBJonathan Barratt
University of Leicester, Leicester General Hospital
- SBStewart Bieler
University of Groningen
Topics & keywords
Topics
Keywords
- Medicine
- Irbesartan
- Renal function
- Proteinuria
- Internal medicine
- Clinical endpoint
- Urology
- Nephropathy
No related works found for this paper.